US · Industrials · Specialty Business Services
EPS came in at 0.43 against a street estimate of 0.40 — a beat of 7.5%.
Analysts rate Dolby Laboratories a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $78.33.
| Fund | Stake |
|---|---|
| BlackRock Inc | 6.98% |
| Morgan Stanley - Brokerage Accounts | 5.49% |
| Vanguard Portfolio Management, LLC | 5.31% |
| Bank of New York Mellon Corp | 4.80% |
| Vanguard Capital Management, LLC | 2.91% |
| State Street Corp | 2.45% |
| First Trust Advisors L.P. | 2.41% |
| Geode Capital Management, LLC | 1.88% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 | 2026-07-30 |
| Results announced · Q3 2026 | 2026-07-30 |
| Quarterly report · Q1 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-30 |
| Shareholder vote results · Q1 2026 | 2026-02-06 |
| Quarterly report · Q4 2025 | 2026-01-29 |
| Results announced · Q1 2026 | 2026-01-29 |
| Proxy statement · Q1 2026 | 2025-12-16 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Dolby Laboratories — free to start.
Google PlayApp StoreData updated 2026-08-05.